Social Cognition in Parkinson's Disease after Focused Ultrasound Subthalamotomy: A Controlled Study.
FUS subthalamotomy
Parkinson's disease
facial emotion recognition
social cognition
theory of mind
Journal
Movement disorders : official journal of the Movement Disorder Society
ISSN: 1531-8257
Titre abrégé: Mov Disord
Pays: United States
ID NLM: 8610688
Informations de publication
Date de publication:
14 Aug 2024
14 Aug 2024
Historique:
revised:
02
07
2024
received:
23
02
2024
accepted:
10
07
2024
medline:
14
8
2024
pubmed:
14
8
2024
entrez:
14
8
2024
Statut:
aheadofprint
Résumé
Social cognition (SC) encompasses a set of cognitive functions that enable individuals to understand and respond appropriately to social interactions. Although focused ultrasound subthalamotomy (FUS-STN) effectively treats Parkinson's disease (PD) clinical motor features, its impact and safety on cognitive-behavioral interactions/interpersonal awareness are unknown. This study investigated the effects of unilateral FUS-STN on facial emotion recognition (FER) and affective and cognitive theory of mind (ToM) in PD patients from a randomized sham-controlled trial (NCT03454425). Subjects performed SC evaluation before and 4 months after the procedure while still under blind assessment conditions. The SC assessment included the Karolinska Directed Emotional Faces task for FER, the Reading the Mind in the Eyes (RME) test for affective ToM, and The Theory of Mind Picture Stories Task (ToM PST) (order, questions, and total score) for cognitive ToM. The active treatment group showed anecdotal-to-moderate evidence of no worsening in SC after FUS-STN. Anecdotal evidence for an improvement was recognized in the SC score changes, from baseline to post-treatment, for the active treatment group compared with sham for the RME, ToM PST order, ToM PST total, FER total, and recognition of fear, disgust, and anger. This study provides the first evidence that unilateral FUS-STN does not impair social cognitive abilities, indicating that it can be considered a safe treatment approach for this domain in PD patients. Furthermore, the results suggest FUS-STN may even lead to some improvement in social cognitive outcomes, which should be considered as a preliminary finding requiring further investigation with larger samples sizes. © 2024 International Parkinson and Movement Disorder Society.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Fundación de Investigación HM Hospitales
Informations de copyright
© 2024 International Parkinson and Movement Disorder Society.
Références
Adolphs R, Adolphs R, Adolphs R, Adolphs R. Social cognition and the human brain. Trends Cogn Sci 1999;3:469–479.
Adolphs R. The neurobiology of social cognition. Curr Opin Neurobiol 2001;11:231–239.
Arioli M, Crespi C, Canessa N. Social cognition through the lens of cognitive and clinical neuroscience. Biomed Res Int 2018;2018:4283427.
Elgh E, Domellöf M, Linder J, Edström M, Stenlund H, Forsgren L. Cognitive function in early Parkinson's disease: a population‐based study. Eur J Neurol 2009;16:1278–1284.
Muslimović D, Post B, Speelman JD, Schmand B. Cognitive profile of patients with newly diagnosed Parkinson disease. Neurology 2005;65:1239–1245.
Bodden ME, Dodel R, Kalbe E. Theory of mind in Parkinson's disease and related basal ganglia disorders: a systematic review. Mov Disord 2010;25:13–27.
Bora E, Walterfang M, Velakoulis D. Theory of mind in Parkinson's disease: a meta‐analysis. Behav Brain Res 2015;292:515–520.
Kan Y, Kawamura M, Hasegawa Y, Mochizuki S, Nakamura K. Recognition of emotion from facial, prosodic and written verbal stimuli in Parkinson's disease. Cortex 2002;38:623–630.
Fernández‐Fernández R, Lahera G, Fernández‐Rodríguez B, Guida P, Trompeta C, Mata‐Marín D, et al. Social cognition and mild cognitive impairment in mid‐stage Parkinson's disease. Behav Sci 2024;14:101.
Assogna F, Pontieri FE, Caltagirone C, Spalletta G. The recognition of facial emotion expressions in Parkinson's disease. Eur Neuropsychopharmacol 2008;18:835–848.
Enrici I, Adenzato M, Ardito RB, Mitkova A, Cavallo M, Zibetti M, et al. Emotion processing in Parkinson's disease: a three‐level study on recognition, representation, and regulation. PLoS One 2015;10:1–18.
Herrera E, Cuetos F, Rodríguez‐Ferreiro J. Emotion recognition impairment in Parkinson's disease patients without dementia. J Neurol Sci 2011;310:237–240.
Suzuki A, Hoshino T, Shigemasu K, Kawamura M. Disgust‐specific impairment of facial expression recognition in Parkinson's disease. Brain 2006;129:707–717.
Wagenbreth C, Wattenberg L, Heinze HJ, Zaehle T. Implicit and explicit processing of emotional facial expressions in Parkinson's disease. Behav Brain Res 2016;303:182–190.
Palmeri R, Lo Buono V, Corallo F, Foti M, Di Lorenzo G, Bramanti P, et al. Nonmotor symptoms in Parkinson disease: a descriptive review on social cognition ability. J Geriatr Psychiatry Neurol 2017;30:109–121.
Argaud S, Vérin M, Sauleau P, Grandjean D. Facial emotion recognition in Parkinson's disease: a review and new hypotheses. Mov Disord 2018;33:554–567.
Péron J, Vicente S, Leray E, Drapier S, Drapier D, Cohen R, et al. Are dopaminergic pathways involved in theory of mind? A study in Parkinson's disease. Neuropsychologia 2009;47:406–414.
Trompeta C, Rodríguez BF, Gasca‐Salas C. What do we know about theory of mind impairment in Parkinson's disease? Behav Sci 2021;11(10):130.
Siquier A, Andrés P. Facial emotion recognition in Parkinson's disease: the role of executive and affective domains. Neuropsychology 2022;36:384–393.
Alonso‐Recio L, Carvajal F, Merino C, Serrano JM. Social cognition and cognitive decline in patients with Parkinson's disease. J Int Neuropsychol Soc 2021;27:744–755.
Romosan AM, Dehelean L, Romosan RS, Andor M, Bredicean AC, Simu MA. Affective theory of mind in parkinson's disease: the effect of cognitive performance. Neuropsychiatr Dis Treat 2019;15:2521–2535.
Maggi G, Muñoz AMC, Obeso I, Santangelo G. Neuropsychological, neuropsychiatric, and clinical correlates of affective and cognitive theory of mind in Parkinson's disease: a meta‐analysis. Neuropsychology 2022;36:483–504.
Mattavelli G, Barvas E, Longo C, Zappini F, Ottaviani D, Malaguti MC, et al. Facial expressions recognition and discrimination in Parkinson's disease. J Neuropsychol 2021;15:46–68.
Mckinlay A, Albicini M, Kavanagh PS. The effect of cognitive status and visuospatial performance on affective theory of mind in Parkinson's disease. Neuropsychiatr Dis Treat 2013;9:1071–1076.
Panopoulou N, Christidi F, Kourtesis P, Ferentinos P, Karampetsou P, Tsirtsiridis G, et al. The association of theory of mind with language and visuospatial abilities in amyotrophic lateral sclerosis: a pilot study. Amyotrophic Lateral Scler Frontotemporal Degener 2022;23:462–469.
Czernecki V, Benchetrit E, Houot M, Pineau F, Mangone G, Corvol JC, et al. Social cognitive impairment in early Parkinson's disease: a novel “mild impairment”? Parkinsonism Relat Disord 2021;85:117–121.
Pietschnig J, Schröder L, Ratheiser I, Kryspin‐Exner I, Pflüger M, Moser D, et al. Facial emotion recognition and its relationship to cognition and depressive symptoms in patients with Parkinson's disease. Int Psychogeriatr 2016;28:1165–1179.
Mengelberg A, Siegert RJ. Is theory‐of‐mind impaired in Parkinson's disease? Cogn Neuropsychiatry 2003;8:191–209.
Temel Y, Blokland A, Steinbusch HWM, Visser‐Vandewalle V. The functional role of the subthalamic nucleus in cognitive and limbic circuits. Prog Neurobiol 2005;76(6):393–413.
Weintraub DB, Zaghloul KA. The role of the subthalamic nucleus in cognition. Rev Neurosci 2013;24:125–138.
Péron J, Frühholz S, Vérin M, Grandjean D. Subthalamic nucleus: a key structure for emotional component synchronization in humans. Neurosci Biobehav Rev 2013;37(3):358–373.
Martínez‐Fernández R, Máñez‐Miró JU, Rodríguez‐Rojas R, delÁlamo M, Shah BB, Hernández‐Fernández F, et al. Randomized trial of focused ultrasound Subthalamotomy for Parkinson's disease. N Engl J Med 2020;383:2501–2513.
Martínez‐Fernández R, Natera‐Villalba E, Máñez Miró JU, Rodriguez‐Rojas R, Marta Del Álamo M, Pineda‐Pardo JÁ, et al. Prospective long‐term follow‐up of focused ultrasound unilateral Subthalamotomy for Parkinson disease. Neurology 2023;100:E1395–E1405.
Schroeder U, Kuehler A, Hennenlotter A, Haslinger B, Tronnier VM, Krause M, et al. Facial expression recognition and subthalamic nucleus stimulation. J Neurol Neurosurg Psychiatry 2004;75:648–650.
Aiello M, Eleopra R, Lettieri C, Mondani M, D'Auria S, Belgrado E, et al. Emotion recognition in Parkinson's disease after subthalamic deep brain stimulation: differential effects of microlesion and STN stimulation. Cortex 2014;51:35–45.
Dujardin K, Blairy S, Defebvre L, Krystkowiak P, Hess U, Dujardin K. Subthalamic nucleus stimulation induces deficits in decoding emotional facial expressions in Parkinson's disease. J Neurol Neurosurg Psychiatry 2004;75:202–208.
Péron J, Biseul I, Leray E, Vicente S, Le Jeune F, Drapier S, et al. Subthalamic nucleus stimulation affects fear and sadness recognition in Parkinson's disease. Neuropsychology 2010;24:1–8.
Albuquerque L, Coelho M, Martins M, Guedes LC, Rosa MM, Ferreira JJ, et al. STN‐DBS does not change emotion recognition in advanced Parkinson's disease. Parkinsonism Relat Disord 2014;20:166–169.
Enrici I, Mitkova A, Castelli L, Lanotte M, Lopiano L, Adenzato M. Deep brain stimulation of the subthalamic nucleus does not negatively affect social cognitive abilities of patients with Parkinson's disease. Sci Rep 2017;7:1–9.
Péron J, leJeune F, Haegelen C, Dondaine T, Drapier D, Sauleau P, et al. Subthalamic nucleus stimulation affects theory of mind network: a PET study in Parkinson's disease. PLoS One 2010;5(3):e9919.
Baggio HC, Segura B, Ibarretxe‐Bilbao N, Valldeoriola F, Marti MJ, Compta Y, et al. Structural correlates of facial emotion recognition deficits in Parkinson's disease patients. Neuropsychologia 2012;50:2121–2128.
Christidi F, Migliaccio R, Santamaría‐García H, Santangelo G, Trojsi F. Social cognition dysfunctions in neurodegenerative diseases: neuroanatomical correlates and clinical implications. Behav Neurol 2018;2018:1849794.
Wilkos E, Brown TJB, Slawinska K, Akucharska K. Social cognitive and neurocognitive deficits in inpatients with unilateral thalamic lesions—pilot study. Neuropsychiatr Dis Treat 2015;11:1031–1038.
Boucher O, Rouleau I, Lassonde M, Lepore F, Bouthillier A, Nguyen DK. Social information processing following resection of the insular cortex. Neuropsychologia 2015;71:1–10.
Adolphs R, Baron‐cohen S, Tranel D. Impaired recognition of social emotions following amygdala damage. J Cogn Neurosci 2002;14:1264–1274.
Okun MS, Fernandez HH, Wu SS, Kirsch‐Darrow L, Bowers D, Bova F, et al. Cognition and mood in Parkinson's disease in subthalamic nucleus versus globus pallidus interna deep brain stimulation: the COMPARE trial. Ann Neurol 2009;65:586–595.
Burdick AP, Foote KD, Wu S, Bowers D, Zeilman P, Jacobson CE, et al. Do patient's get angrier following STN, GPi, and thalamic deep brain stimulation. Neuroimage 2011;54 Suppl 1:S227–S232.
Lundqvist D, Flykt A, Öhman A. The Karolinska Directed Emotional Faces—KDEF (CD ROM). [Internet]. Stockholm, Sweden: Department of Clinical Neuroscience, Psychology section, Karolinska Institutet; 1998.
Calvo MG, Lundqvist D. Facial expressions of emotion (KDEF): identification under different display‐duration conditions. Behav Res Methods 2008;40:109–115.
Statucka M, Walder DJ. Facial affect recognition and social functioning among individuals with varying degrees of schizotypy. Psychiatry Res 2017;256:180–187.
Benton AL, Van Allen MW. Impairment in facial recognition in patients with cerebral disease. Cortex 1968;4:344‐IN1.
Baron‐Cohen S, Wheelwright S, Hill J, Raste Y, Plumb I. The “Reading the mind in the eyes” test revised version: a study with Normal adults, and adults with Asperger syndrome or high‐functioning autism. J Child Psychol Psychiatry 2001;42:241–251.
Fernández‐Abascal EG, Cabello R, Fernández‐Berrocal P, Baron‐Cohen S. Test‐retest reliability of the “Reading the mind in the eyes” test: a one‐year follow‐up study. Mol Autism 2013;4(1):33.
Brüne M. Theory of mind and the role of IQ in chronic disorganized schizophrenia. Schizophr Res 2003;60:57–64.
Keysers C, Gazzola V, Wagenmakers E‐J. Author correction: using Bayes factor hypothesis testing in neuroscience to establish evidence of absence. Nat Neurosci 2020;23(11):1453–1453.
Obeso I, Casabona E, Rodríguez‐Rojas R, Bringas ML, Macías R, Pavón N, et al. Unilateral subthalamotomy in Parkinson's disease: cognitive, psychiatric and neuroimaging changes. Cortex 2017;94:39–48.
Rodriguez‐Rojas R, Pineda‐Pardo JA, Mañez‐Miro J, Sanchez‐Turel A, Martinez‐Fernandez R, delAlamo M, et al. Functional topography of the human subthalamic nucleus: relevance for Subthalamotomy in Parkinson's disease. Mov Disord 2022;37:279–290.
Ashkan K, Rogers P, Bergman H, Ughratdar I. Insights into the mechanisms of deep brain stimulation. Nat Rev Neurol 2017;13(9):548–554.
Juri C, Rodriguez‐Oroz MC, Obeso JA. The pathophysiological basis of sensory disturbances in Parkinson's disease. J Neurol Sci 2010;289:60–65.
Rodriguez‐Rojas R, Pineda‐Pardo JA, Martinez‐Fernandez R, Kogan RV, Sanchez‐Catasus CA, delAlamo M, et al. Functional impact of subthalamotomy by magnetic resonance–guided focused ultrasound in Parkinson's disease: a hybrid PET/MR study of resting‐state brain metabolism. Eur J Nucl Med Mol Imaging 2020;47:425–436.
Su PC, Yilong M, Fukuda M, Mentis MJ, Tseng HM, Yen RF, et al. Metabolic changes following subthalamotomy for advanced Parkinson's disease. Ann Neurol 2001;50:514–520.
Hirsch EC, Périer C, Orieux G, François C, Féger J, Ome Yelnik J, et al. Metabolic effects of nigrostriatal denervation in basal ganglia. Trends Neurosci 2000;23:S78–S85.
Artieda J, Pastor MA, Lacruz F, Obeso JA. Temporal discrimination is abnormal in Parkinson's disease. Brain 1992;115:199–210.
Ordás CM, Alonso‐Frech F, González‐Monje MH, Martínez‐Fernández R, Máñez‐Miró J, Del Álamo M, et al. Somatosensory temporal discrimination threshold improves after unilateral HIFU subthalamotomy in asymmetrical PD‐MDS Abstracts 2020.
Martínez‐Fernández R, Natera‐Villalba E, Rodríguez‐Rojas R, delÁlamo M, Pineda‐Pardo JA, Obeso I, et al. Staged bilateral MRI‐guided focused ultrasound Subthalamotomy for Parkinson disease. JAMA Neurol 2024;81:638–644.
Gotham AM, Brown RG, Marsden CD. “Frontal” cognitive function in patients with Parkinson's disease “on” and “off” levodopa. Brain 1988;111(2):299–321.
Gotham AM, Brown RG, Marsden CD. Levodopa treatment may benefit or impair “frontal” function in Parkinson's disease. Lancet 1986;2:970–971.
Swainson R, Rogers RD, Sahakian BJ, Summers BA, Polkey CE, Robbins TW. Probabilistic learning and reversal deficits in patients with Parkinson's disease or frontal or temporal lobe lesions: possible adverse effects of dopaminergic medication. Neuropsychologia 2000;38:596–612.
Kosutzka Z, Kralova M, Kusnirova A, Papayova M, Valkovic P, Csefalvay Z, et al. Neurocognitive predictors of understanding of intentions in Parkinson disease. J Geriatr Psychiatry Neurol 2019;32:178–185.
Péron J, Grandjean D, Drapier S, Vérin M. Effect of dopamine therapy on nonverbal affect burst recognition in Parkinson's disease. PLoS One 2014;9(3):e90092.
Sprengelmeyer R, Young AW, Mahn K, Schroeder U, Woitalla D, Büttner T, et al. Facial expression recognition in people with medicated and unmedicated Parkinson's disease. Neuropsychologia 2003;41:1047–1057.
Del Prete E, Turcano P, Unti E, Palermo G, Pagni C, Frosini D, et al. Theory of mind in Parkinson's disease: evidences in drug‐naïve patients and longitudinal effects of dopaminergic therapy. Neurol Sci 2020;41:2761–2766.
Roca M, Torralva T, Gleichgerrcht E, Chade A, Arévalo GG, Gershanik O, et al. Impairments in social cognition in early medicated and unmedicated Parkinson disease. Cogn Behav Neurol 2010;23:152–158.
Usnich T, Krasivskaya E, Klostermann F. Theory of mind deficits in Parkinson's disease are not modulated by dopaminergic medication. Front Neurol 2023;14:1208638.
Siripurapu G, Verma B, Biswas D, Reghu A, Vishnoi A, Radhakrishnan DM, et al. Social cognition in Parkinson's disease: a case‐control study. Mov Disord Clin Pract 2023;10:399.
Stirnimann N, N'Diaye K, Le JF, Houvenaghel JF, Robert G, Drapier S, et al. Hemispheric specialization of the basal ganglia during vocal emotion decoding: evidence from asymmetric Parkinson's disease and 18FDG PET. Neuropsychologia 2018;119:1–11.
Voruz P, Le Jeune F, Haegelen C, N'Diaye K, Houvenaghel JF, Sauleau P, et al. Motor symptom asymmetry in Parkinson's disease predicts emotional outcome following subthalamic nucleus deep brain stimulation. Neuropsychologia 2020;144:107494.
Benis D, Haegelen C, Voruz P, Pierce J, Milesi V, Houvenaghel JF, et al. Subthalamic nucleus oscillations during vocal emotion processing are dependent of the motor asymmetry of Parkinson's disease. Neuroimage 2020;222:117215.
Voruz P, Pierce J, Ahrweiller K, Haegelen C, Sauleau P, Drapier S, et al. Motor symptom asymmetry predicts non‐motor outcome and quality of life following STN DBS in Parkinson's disease. Sci Rep 2022;12:3007.
Voruz P, Haegelen C, Assal F, Drapier S, Drapier D, Sauleau P, et al. Motor symptom asymmetry predicts cognitive and neuropsychiatric profile following deep brain stimulation of the subthalamic nucleus in Parkinson's disease: a 5‐year longitudinal study. Arch Clin Neuropsychol 2023;38:904–912.